ID   DM14 [Human melanoma]
AC   CVCL_6622
SY   Duke Melanoma 14
DR   Wikidata; Q54831200
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=10752474;
RX   PubMed=14871852;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*11,68; B*05,08; C*02,04 (PubMed=10752474).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
RX   PubMed=2404572;
RA   Crowley N.J., Slingluff C.L. Jr., Darrow T.L., Seigler H.F.;
RT   "Generation of human autologous melanoma-specific cytotoxic T-cells
RT   using HLA-A2-matched allogeneic melanomas.";
RL   Cancer Res. 50:492-498(1990).
//
RX   PubMed=2785141; DOI=10.4049/jimmunol.142.9.3329;
RA   Darrow T.L., Slingluff C.L. Jr., Seigler H.F.;
RT   "The role of HLA class I antigens in recognition of melanoma cells by
RT   tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor
RT   antigens.";
RL   J. Immunol. 142:3329-3335(1989).
//
RX   PubMed=10752474; DOI=10.1007/s002620050015; PMCID=PMC11037162;
RA   Slingluff C.L. Jr., Colella T.A., Thompson L., Graham D.D.,
RA   Skipper J.C.A., Caldwell J., Brinckerhoff L., Kittlesen D.J.,
RA   Deacon D.H., Oei C., Harthun N.L., Huczko E.L., Hunt D.F.,
RA   Darrow T.L., Engelhard V.H.;
RT   "Melanomas with concordant loss of multiple melanocytic
RT   differentiation proteins: immune escape that may be overcome by
RT   targeting unique or undefined antigens.";
RL   Cancer Immunol. Immunother. 48:661-672(2000).
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan K.T., Coppola M.A., Gatlin C.L., Thompson L.W., Shabanowitz J.,
RA   Hunt D.F., Engelhard V.H., Ross M.M., Slingluff C.L. Jr.;
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//